Does DARATUMUMAB\HYALURONIDASE-FIHJ Cause Off label use? 109 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Off label use have been filed in association with DARATUMUMAB\HYALURONIDASE-FIHJ. This represents 4.3% of all adverse event reports for DARATUMUMAB\HYALURONIDASE-FIHJ.
109
Reports of Off label use with DARATUMUMAB\HYALURONIDASE-FIHJ
4.3%
of all DARATUMUMAB\HYALURONIDASE-FIHJ reports
9
Deaths
18
Hospitalizations
How Dangerous Is Off label use From DARATUMUMAB\HYALURONIDASE-FIHJ?
Of the 109 reports, 9 (8.3%) resulted in death, 18 (16.5%) required hospitalization, and 4 (3.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB\HYALURONIDASE-FIHJ. However, 109 reports have been filed with the FAERS database.
What Other Side Effects Does DARATUMUMAB\HYALURONIDASE-FIHJ Cause?
Product dose omission issue (189)
Dyspnoea (112)
Fatigue (101)
Pyrexia (86)
Nausea (80)
Pneumonia (78)
Plasma cell myeloma (74)
Diarrhoea (71)
Neutropenia (70)
Infusion related reaction (66)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DARATUMUMAB\HYALURONIDASE-FIHJ Alternatives Have Lower Off label use Risk?
DARATUMUMAB\HYALURONIDASE-FIHJ vs DARBEPOETIN ALFA
DARATUMUMAB\HYALURONIDASE-FIHJ vs DARIDOREXANT
DARATUMUMAB\HYALURONIDASE-FIHJ vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB\HYALURONIDASE-FIHJ vs DAROLUTAMIDE
DARATUMUMAB\HYALURONIDASE-FIHJ vs DARUNAVIR